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This study was undertaken to characterize endogenous digitalis-like activity in water extract from mamma- 
lian tissues. Prepuritied samples obtained from guinea-pig heart were analysed by reverse-phase HPLC using 
an acetonitrile gradient. The eluent was assayed for its activity as inhibitor of human heart Na+,K+-ATPase 
and digoxin-like immunoreactivity. Both activities were recovered in the same fraction after two successive 
chromatographic steps. These results provide further evidence for the presence of an endogenous digitalis- 
like factor, cardiodigin, in mammalian heart. 
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1. INTRODUCTION 
In recent years, a body of experimental evidence 
has been accumulated that favors the existence of 
a physiological regulator of the sodium pump. 
This factor could play an important role in the 
regulation of sodium excretion [l-3], in the 
mechanism of action of cardiac glycosides [4-61 
and in the pathogeny of hypertension [7-91. 
We have reported the presence in water extracts 
of mammalian heart of a factor that cross-reacts 
with digoxin antibodies and inhibits Na+,K+- 
ATPase [lo]. This inhibition is specific, reversible, 
antagonized by potassium and shows species 
dependency. In addition, the factor displaces 
specifically bound ouabain. 
Here, we report that when a guinea-pig heart ex- 
tract is further purified using two-step reverse- 
phase HPLC, the peak for inhibition of 
Na+,K+-ATPase coincides with the peak for 
specific reactivity with digoxin antibodies. This 
confirms that the factor so far identified and 
* To whom correspondence should be addressed 
previously coined cardiodigin has characteristics 
analogous to digitalis. 
2. MATERIALS AND METHODS 
2.1. Digitalis-like factor preparation 
Guinea-pig hearts were extracted with water by 
the method in [3], slightly modified. 
Shortly, after centrifugation and extraction by 
methanol, the dry residue obtained from 50 g 
tissue (from about 60 guinea-pigs) was taken up in 
10 ml water and extracted 3 times with 10 ml 
cyclohexane to remove lipids. After lyophilization 
of the aqueous phase, dry residue equivalent o 6 g 
original tissue was dissolved in 0.3 ml water and 
applied to a Bond Elut Cl8 extraction column 
(Analyticem International). The elution was car- 
ried out with 3 x 2 ml water and 3 x 1 ml 
methanol. This last phase was then evaporated at 
40°C under low pressure. 
2.2. High performance liquid chromatography 
To purify further the extract, HPLC was per- 
formed using a Hewlett-Packard HP-1084B 
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chromatograph. The extract was injected into a 
Lichrosorbw RP-8, 5 pm column (250 x 4 mm) 
(Merck) combined with a precolumn (30 x 4 mm), 
filled with Lichroprep RP-8,25-40 ,um, previously 
equilibrated with 20% acetonitrile in water (Bur- 
dick & Jackson, HPLC grade). Elution was carried 
out at a flow rate of 1 ml/min, with a gradient of 
20-50070 acetonitrile in water. Fractions were col- 
lected every 2 min, during 20 min, lyophilized and 
tested for immunoreactivity. Corticosterone, 
chosen as external standard [RT = 16.24 min + 
0.10 (n = 6)] was injected after every fourth injec- 
tion of the extract. When its retention time dif- 
fered by more than 0.3 min from the mean reten- 
tion time of 16.24 min, the system was washed. In 
addition, the precolumn was replaced. 
2.3. Enzymatic assay 
Preparation of human heart Na+,K+-ATPase 
was performed as in [ 111. Usually 1.5-3 pg enzyme 
protein was incubated for 1 h at 37°C in a medium 
containing 100 mM NaCl, 3 mM KCl, 3 mM 
MgC12, 3 mM [32P]ATP (Amersham), 1 mM 
EGTA and 20 mM maleate-Tris, pH 7.4. The final 
volume was 0.1 ml. The reaction was stopped by 
the addition of 0.2 ml chilled dextran charcoal 
suspension in 0.1 M HCl (0.2 g/ml). Total 
ATPase activity was determined by the method of 
Bais [ 121. Basal ATPase activity was determined in 
the absence of KC1 and in the presence of 1 mM 
ouabain. Na+,K+-ATPase activity was calculated 
as the difference between total and basal activities. 
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2.4. Radioimmunoassay 
Digoxin RIA kit was purchased from Becton 
Dickinson. Extract and cardiac glycoside dilutions 
were prepared in a buffer containing 5.5 mM 
KH2P04, 55 mM NazHPOd, 7.7 mM NaN3 and 
60 g/l bovine serum albumin. 
The assay procedure was essentially as described 
by De Pover et al. [lo]. The reaction was stopped 
by the addition of 0.5 ml of a dextran-charcoal 
suspension. After centrifugation and decantation, 
the radioactivity of the pellet was counted. 
3. RESULTS 
Digoxin antibodies and tracer, 1251-labeled 
digoxin derivative, were incubated in the presence 
of various concentrations of digoxin or guinea-pig 
heart extract, obtained after Bond Elut Cl8 
chromatography. Fig. 1 illustrates a typical experi- 
ment. Digoxin displaced the tracer bound to the 
antibodies yielding a sigmoidal displacement curve 
(fig.lb). The displacement curve obtained with 
guinea-pig extract was parallel to that of digoxin 
(fig.la). As shown in [3], this allowed expression 
of the concentration of the immunoreactive factor 
in digoxin RIA equivalents. In 14 successive 
preparations, the yield of the extraction procedure 
was 0.22 f 0.05 pmol/g wet wt tissue (mean + SE). 
The extract was further analyzed by RP-HPLC. 
As shown in fig.2, digoxin-like immunoreactivity 
was detected in fractions 5 (8-10 min) to 8 
(14-16 min) and peaked in fraction 6 (lo-12 min). 
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Fig. 1. Radioimmunoassay of guinea-pig heart extract obtained after Bond Elut Cl8 chromatography (a) and fraction 
6’ obtained after RP-HPLC (c), compared to digoxin (b). 
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Fig.2. Reverse-phase HPLC of guinea-pig . . . - .~~ 
0 
extract 
obtamed after Bond Elut Cl8 chromatography. The 
extract was injected in aliquots from about 15 g tissue, 
into a Lichrosorb@ RP-8, 5 ,um column (250 x 4 mm). 
Fractions obtained from 33 successive runs were pooled, 
lyophilized and assayed for radioimmunological 
activity. The RIA-response, corresponding to 309 g 
tissue/ml is expressed in pmol digoxin RIA eq./ml. 
The total recovery was about 84%; 46.3% of the 
initial radioimmunoactivity was recovered in frac- 
tion 6 (lo-12 min). However, after this first 
HPLC step, there was no correlation between the 
immunological and the Na+,K+-ATPase inhibitory 
responses: inhibitory activities were also found in 
fractions collected between 6 and 20 min (not 
shown). Therefore, fraction 6 was rechroma- 
tographed under the same conditions as the crude 
extract. As illustrated in fig.3a, fraction 6 led to 
only one radioimmunological peak with the same 
retention time as that obtained after the first 
HPLC analysis (fraction 6’). The recovery was 
about 94.4% in fraction 6’. As shown in fig.lc, 
the digoxin-RIA displacement curve obtained with 
fraction 6’ was parallel to those given by digoxin 
and the Bond Elut extract. 
Fraction 6’ and adjacent fractions were tested 
for their inhibitory activity on human heart 
Na+,K+-ATPase. The bulk of inhibitory activity 
was detected in fraction 6’ (fig.3b). This fraction 
gave a dose-dependent inhibition superposable to 
that of digoxin when its content in cardiodigin was 
expressed in digoxin-RIA equivalents (fig.4). The 
Hill coefficients calculated by linear regression 
were 0.94 + 0.02 and 1.01 f 0.11 for fraction 6’ 
and digoxin, respectively. Furthermore, Dixon 
plots (not shown) were straight lines suggesting 
that inhibition obeyed the mass-action law. 
- 
__-- 
,__________.____________ 
TIN (min.) 
- 
._-- 
TIVE (min.) 
.__--- ________________ 
Fig.3. (a) Reverse-phase HPLC of fraction 6 
(lo-12 min) obtained as described in fig.2. 9 runs of 
about 15 g tissue were performed, using the same 
column and gradient as described in fig.2. The RIA 
response, corresponding to 27.3 g tissue/ml is expressed 
in pmol digoxin RIA eq./ml. (b) Human heart 
Na+,K+-ATPase inhibition of each 2 min fraction, 
obtained as in (a). The inhibitory response, expressed in 
percent, was obtained with 20 pl of each HPLC fraction. 
This volume of fraction corresponds to 41 g tissue. 
4. DISCUSSION 
Here, we report the development of a RP-HPLC 
method applied to guinea-pig heart extract, which 
yielded a fraction that cross-reacted with digoxin 
antibodies and evoked a dose-dependent inhibition 
of human heart Na+,K+-ATPase. These results 
confirm our previous data obtained with a less 
purified preparation [lo]. 
A digoxin-like immunoreactivity has been 
reported in mammalian blood [3,13-181, urine 
[1,19] and tissue extracts [3,4,20]. This im- 
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Fig.4. Inhibition of human heart Na+,K+-ATPase by 
fraction 6’ (0) and digoxin (0). Values are means of 
triplicate determinations and representative of two 
different experiments. 
munoreactivity does not always correlate with 
Na+,K+-ATPase inhibitory activity [16,17,21]. 
Such discrepancies could be related to a lack of 
specificity of antibodies as well as to interference 
with the RIA reaction [22-241. This is unlikely in 
view of similar results obtained in the present study 
and in a previous one [lo] with antibodies from 
two different sources (Diagnostic Products Corp. 
and Becton Dickinson). Both preparations 
discriminated digoxin from digitoxin, two 
molecules differing only in the presence of one OH 
group in the C 12@ position [lo]. This indicates 
that cardiodigin is not an occasional aspecific in- 
terference but a chemical entity endowed with 
structural features critical for its recognition by 
antibodies. 
Some extraction and purification procedures 
may yield non-specific RIA cross-reacting 
substances and/or non-specific Na+,K+-ATPase 
inhibitors [10,25,26]. In our experiments, we 
found that after the first HPLC step, 
Na+,K+-ATPase inhibitory activity was detected in 
fractions that did not contain digoxin-like im- 
munoreactivity. However, after a second HPLC 
separation, both activities were recovered in the 
same fraction. A good correlation has also been 
found by Gruber et al. [ 151 after HPLC analysis of 
plasma of volume expanded dogs. Similarly, in 
TLC fractions of rabbit adrenal extract, Schreiber 
et al. [20] found a marked but not complete 
parallelism between the inhibition of 86Rb uptake 
and the immunoreactivity. 
Further studies are still required for the elucida- 
tion of the biological significance and for the 
determination of the chemical structure of 
cardiodigin. 
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